Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03520777
Other study ID # 30498
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 19, 2017
Est. completion date June 30, 2018

Study information

Verified date July 2018
Source Dartmouth-Hitchcock Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to assess the feasibility of a Creative Artists Program intervention with epilepsy and headache patients admitted to Dartmouth-Hitchcock Medical Center for care by the Department of Neurology.


Description:

Qualifying patients admitted to Epilepsy monitoring or Headache treatment will be approached for participation in the study. Patients who consent to the study will be given a chance to work with one of three creative artists (visual artist, creative writer, therapeutic musician). The artist will be selected according to a pre-determined schedule, and the arts intervention may last up to 90 minutes. Subjects will be asked to complete study questionnaires before and after the arts intervention.


Recruitment information / eligibility

Status Completed
Enrollment 33
Est. completion date June 30, 2018
Est. primary completion date June 1, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Age > or = 18 years

2. Diagnosis of refractory chronic epilepsy, status migrainosus, or chronic daily headache

3. Elective admission to the Dartmouth-Hitchcock Medical Center Epilepsy monitoring unit or Headache service

4. Capable of giving informed consent

Exclusion Criteria:

1. Active psychiatric illness that prohibits safe visitation by artists

2. Impairment of vision or hearing that would prohibit able to participate with participation in instructions necessary for the interventions.

3. Active general medical condition that would impair consciousness.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Art Intervention
Type of artist intervention will be determined by the subject and the assigned artist.

Locations

Country Name City State
United States Dartmouth-Hitchcock Medical Center Lebanon New Hampshire

Sponsors (1)

Lead Sponsor Collaborator
Dartmouth-Hitchcock Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility of conducting a creative arts intervention study The feasibility of the creative intervention will be determined by the completion rates of the initial intervention attempts. If less than 50% of patients complete the intervention it will be deemed unfeasible in the current format. Through study completion, approximately 1 year
Secondary Change in patient anxiety before and after the intervention Change in anxiety level will be calculated, based on patient questionnaire responses, following the creative intervention. Each patient will be assessed at baseline (Day 1) and after the intervention (approximately Day 3 - 21).
Secondary Change in patient distress before and after the intervention Change in distress level will be calculated, based on patient questionnaire responses, following the creative intervention. Each patient will be assessed at baseline (Day 1) and after the intervention (approximately Day 3 - 21).
Secondary Change in patient depression before and after the intervention Change in depression level will be calculated, based on patient questionnaire responses, following the creative intervention. Each patient will be assessed at baseline (Day 1) and after the intervention (approximately Day 3 - 21).
Secondary Change in frequency of as-needed pain medication use As-needed pain medication utilization will be evaluated following the creative arts intervention through subject discharge. Each patient as-needed medication use will be assessed after the arts intervention and until discharge from the hospital (approximately Day 3 - 21).
Secondary Length of hospital stay Length of hospital stay will be calculated. Each patient's admission duration (approximately 3 - 21 Days).
See also
  Status Clinical Trial Phase
Completed NCT04595513 - Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants Phase 1/Phase 2
Completed NCT02909387 - Adapting Project UPLIFT for Blacks in Georgia N/A
Completed NCT05552924 - Self Acupressure on Fatigue and Sleep Quality in Epilepsy Patients N/A
Terminated NCT01668654 - Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS Phase 3
Not yet recruiting NCT05068323 - Impact of Interictal Epileptiform Activity on Some Cognitive Domains in Newly Diagnosed Epileptic Patients N/A
Completed NCT03994718 - Creative Arts II Study N/A
Recruiting NCT04076449 - Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
Completed NCT00782249 - Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy N/A
Completed NCT03683381 - App-based Intervention for Treating Insomnia Among Patients With Epilepsy N/A
Recruiting NCT05101161 - Neurofeedback Using Implanted Deep Brain Stimulation Electrodes N/A
Active, not recruiting NCT06034353 - Impact of Pharmacist-led Cognitive Behavioral Intervention on Adherence and Quality of Life of Epileptic Patients N/A
Recruiting NCT05769933 - Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
Not yet recruiting NCT06408428 - Glioma Intraoperative MicroElectroCorticoGraphy N/A
Not yet recruiting NCT05559060 - Comorbidities of Epilepsy(Cognitive and Psychiatric Dysfunction)
Completed NCT02977208 - Impact of Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use Phase 4
Completed NCT02646631 - Behavioral and Educational Tools to Improve Epilepsy Care N/A
Completed NCT02952456 - Phenomenological Approach of Epilepsy in Patients With Epilepsy
Recruiting NCT02539134 - TAK-935 Multiple Rising Dose Study in Healthy Participants Phase 1
Completed NCT02491073 - Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL) N/A
Terminated NCT02757547 - Transcranial Magnetic Stimulation for Epilepsy N/A